Effects of chondroitin sulfate in the pathophysiology of the osteoarthritic joint: a narrative review

Osteoarthritis and Cartilage

Volumn 18, Issue SUPPL. 1, 2010, Pages

  Martel Pelletier, J ^a   Kwan Tat, S ^a   Pelletier, J P ^a  

^a NOTRE DAME HOSPITAL   (Canada)

Author keywords

Articular tissues; Cartilage; Chondroition sulfate; Subchondral bone; Synovial membrane

Indexed keywords

CHONDROITIN SULFATE; CYCLOOXYGENASE 2; GLUCOSAMINE SULFATE; GLYCOSAMINOGLYCAN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MATRIX METALLOPROTEINASE; OSTEOPROTEGERIN; PLACEBO; PROSTAGLANDIN E2; PROTEOGLYCAN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; ANTIINFLAMMATORY AGENT;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CARTILAGE MATRIX; CATABOLISM; CELL DEATH; CLINICAL TRIAL; DRUG ABSORPTION; ENZYME DEGRADATION; HUMAN; KNEE PAIN; MEDLINE; NONHUMAN; OSTEOARTHRITIS; OSTEOBLAST; OSTEOLYSIS; PATHOPHYSIOLOGY; PEER REVIEW; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; BONE REMODELING; DRUG EFFECTS; METABOLISM; SYNOVIUM;

ANTI-INFLAMMATORY AGENTS; BONE REMODELING; CARTILAGE, ARTICULAR; CHONDROITIN SULFATES; HUMANS; OSTEOARTHRITIS; SYNOVIAL MEMBRANE;

EID: 77953775543     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2010.01.015     Document Type: Article

References (41)

1. Martel-Pelletier J., Lajeunesse D., Pelletier J.P. Etiopathogenesis of osteoarthritis. Arthritis & Allied Conditions. A Textbook of Rheumatology 2005, 2199-2226. Lippincott, Williams & Wilkins, Baltimore. 15th edn. W.J. Koopman, L.W. Moreland (Eds.).
2. Martel-Pelletier J., Lajeunesse D., Reboul P., Pelletier J.P. The role of subchondral bone in osteoarthritis. Osteoarthritis: a Companion to Rheumatology 2007, 15-32. Mosby Elsevier, Philadelphia, USA. 1st edn. L. Sharma, F. Berenbaum (Eds.).
3. Conte A., de Bernardi M., Palmieri L., Lualdi P., Mautone G., Ronca G. Metabolic fate of exogenous chondroitin sulfate in man. Arzneimittelforschung 1991, 41:768-772.
4. Conte A., Palmieri L., Segnini D., Ronca G. Metabolic fate of partially depolymerized chondroitin sulfate administered to the rat. Drugs Exp Clin Res 1991, 17:27-33.
5. Conte A., Volpi N., Palmieri L., Bahous I., Ronca G. Biochemical and pharmacokinetic aspects of oral treatment with chondroitin sulfate. Arzneimittelforschung 1995, 45:918-925.
6. Palmieri L., Conte A., Giovannini L., Lualdi P., Ronca G. Metabolic fate of exogenous chondroitin sulfate in the experimental animal. Arzneimittelforschung 1990, 40:319-323.
7. Ronca F., Palmieri L., Panicucci P., Ronca G. Anti-inflammatory activity of chondroitin sulfate. Osteoarthritis Cartilage 1998, 6(Suppl A):14-21.
8. Volpi N. Oral bioavailability of chondroitin sulfate (Condrosulf) and its constituents in healthy male volunteers. Osteoarthritis Cartilage 2002, 10:768-777.
9. Maneiro E., Fernández Sueiro J., Lema D., de Toro F., Galdo F., Blanco F. Efecto del condroitín sulfato sobre la producción de óxido nítrico por los condrocitos humanos artrósicos. Rev Esp Reumatol 2001, 28:12-17.
10. Vergés J., Montell E., Martinez G., Heroux L., du Souich P. Chondroitin sulfate reduces nuclear translocation factor NF-kappaB and does not modify the activation state of activating protein-1 (AP-1). Osteoarthritis Cartilage 2004, 12:194. (Abstract).
11. Jomphe C., Gabriac M., Hale T.M., Heroux L., Trudeau L.E., Deblois D., et al. Chondroitin sulfate inhibits the nuclear translocation of nuclear factor-kappaB in interleukin-1beta-stimulated chondrocytes. Basic Clin Pharmacol Toxicol 2008, 102:59-65.
12. Caraglia M., Beninati S., Giuberti G., D'Alessandro A.M., Lentini A., Abbruzzese A., et al. Alternative therapy of earth elements increases the chondroprotective effects of chondroitin sulfate in mice. Exp Mol Med 2005, 37:476-481.
13. Bassleer C.T., Combal J.P., Bougaret S., Malaise M. Effects of chondroitin sulfate and interleukin-1 beta on human articular chondrocytes cultivated in clusters. Osteoarthritis Cartilage 1998, 6:196-204.
14. Uebelhart D., Thonar E.J., Zhang J., Williams J.M. Protective effect of exogenous chondroitin 4,6-sulfate in the acute degradation of articular cartilage in the rabbit. Osteoarthritis Cartilage 1998, 6(Suppl A):6-13.
15. Wang L., Wang J., Almqvist K.F., Veys E.M., Verbruggen G. Influence of polysulphated polysaccharides and hydrocortisone on the extracellular matrix metabolism of human articular chondrocytes in vitro. Clin Exp Rheumatol 2002, 20:669-676.
16. Orth M.W., Peters T.L., Hawkins J.N. Inhibition of articular cartilage degradation by glucosamine-HCl and chondroitin sulphate. Equine Vet J Suppl 2002, 34:224-229.
17. Chan P.S., Caron J.P., Orth M.W. Effect of glucosamine and chondroitin sulfate on regulation of gene expression of proteolytic enzymes and their inhibitors in interleukin-1-challenged bovine articular cartilage explants. Am J Vet Res 2005, 66:1870-1876.
18. Chou M.M., Vergnolle N., McDougall J.J., Wallace J.L., Marty S., Teskey V., et al. Effects of chondroitin and glucosamine sulfate in a dietary bar formulation on inflammation, interleukin-1beta, matrix metalloprotease-9, and cartilage damage in arthritis. Exp Biol Med 2005, 230:255-262.
19. Monfort J., Nacher M., Montell E., Vila J., Verges J., Benito P. Chondroitin sulfate and hyaluronic acid (500-730kDa) inhibit stromelysin-1 synthesis in human osteoarthritic chondrocytes. Drugs Exp Clin Res 2005, 31:71-76.
20. Baici A., Bradamante P. Interaction between human leukocyte elastase and chondroitin sulfate. Chem Biol Interact 1984, 51:1-11.
21. Baici A., Lang A. Cathepsin B secretion by rabbit articular chondrocytes: modulation by cycloheximide and glycosaminoglycans. Cell Tissue Res 1990, 259:567-573.
22. Verbruggen G., Veys E.M. Influence of sulphated glycosaminoglycans upon proteoglycan metabolism of the synovial lining cells. Acta Rhumatol Belg 1977, 1:75-92.
23. Nishikawa H., Mori I., Umemoto J. Influences of sulfated glycosaminoglycans on biosynthesis of hyaluronic acid in rabbit knee synovial membrane. Arch Biochem Biophys 1985, 240:146-153.
24. Nishikawa H., Mori I., Umemoto J. Glycosaminoglycan polysulfate-induced stimulation of hyaluronic acid synthesis in rabbit knee synovial membrane: involvement of binding protein and calcium ion. Arch Biochem Biophys 1988, 266:201-209.
25. Chan P.S., Caron J.P., Rosa G.J., Orth M.W. Glucosamine and chondroitin sulfate regulate gene expression and synthesis of nitric oxide and prostaglandin E(2) in articular cartilage explants. Osteoarthritis Cartilage 2005, 13:387-394.
26. Chan P.S., Caron J.P., Orth M.W. Short-term gene expression changes in cartilage explants stimulated with interleukin beta plus glucosamine and chondroitin sulfate. J Rheumatol 2006, 33:1329-1340.
27. Omata T., Sagawa Y., Itosaku Y., Inoue N., Tanaka Y. Effects of chondroitin sulphate-C on bradykinin-induced proteoglycan depletion in rats. Arzneimittelforschung 2000, 49:577-581.
28. Cho S.Y., Sim J.S., Jeong C.S., Chang S.Y., Choi D.W., Toida T., et al. Effects of low molecular weight chondroitin sulfate on type II collagen-induced arthritis in DBA/1J mice. Biol Pharm Bull 2004, 27:47-51.
29. Albertini R., Passi A., Abuja P.M., De Luca G. The effect of glycosaminoglycans and proteoglycans on lipid peroxidation. Int J Mol Med 2000, 6:129-136.
30. Campo G.M., Avenoso A., Campo S., Ferlazzo A.M., Altavilla D., Calatroni A. Efficacy of treatment with glycosaminoglycans on experimental collagen-induced arthritis in rats. Arthritis Res Ther 2003, 5:R122-R131.
31. Campo G.M., Avenoso A., Campo S., D'Ascola A., Ferlazzo A.M., Calatroni A. Reduction of DNA fragmentation and hydroxyl radical production by hyaluronic acid and chondroitin-4-sulphate in iron plus ascorbate-induced oxidative stress in fibroblast cultures. Free Radic Res 2004, 38:601-611.
32. Campo G.M., Avenoso A., Campo S., Ferlazzo A., Altavilla D., Micali C., et al. Aromatic trap analysis of free radicals production in experimental collagen-induced arthritis in the rat: protective effect of glycosaminoglycans treatment. Free Radic Res 2003, 37:257-268.
33. Clegg D.O., Reda D.J., Harris C.L., Klein M.A., O'Dell J.R., Hooper M.M., et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med 2006, 354:795-808.
34. Seibel M.J., Duncan A., Robins S.P. Urinary hydroxy-pyridinium crosslinks provide indices of cartilage and bone involvement in arthritic diseases. J Rheumatol 1989, 16:964-970.
35. Sowers M., Zobel D., Weissfeld L., Hawthorne V.M., Carman W. Progression of osteoarthritis of the hand and metacarpal bone loss. A twenty-year followup of incident cases. Arthritis Rheum 1991, 34:36-42.
36. Li B., Marshall D., Roe M., Aspden R.M. The electron microscope appearance of the subchondral bone plate in the human femoral head in osteoarthritis and osteoporosis. J Anat 1999, 195(Pt 1):101-110.
37. Kwan Tat S., Pelletier J.P., Lajeunesse D., Fahmi H., Lavigne M., Martel-Pelletier J. The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells. Clin Exp Rheumatol 2008, 26:295-304.
38. Couchourel D., Aubry I., Delalandre A., Lavigne M., Martel-Pelletier J., Pelletier J.-P., et al. Altered mineralization of human osteoarthritic osteoblasts is due to abnormal collagen type 1 production. Arthritis Rheum 2009, 60:1438-1450.
39. Tat S.K., Pelletier J.P., Vergés J., Montell E., Lajeunesse D., Fahmi H., et al. Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts. Arthritis Res Ther 2007, 9:R117.
40. Kwan Tat S., Pelletier J.-P., Mineau F., Duval N., Martel-Pelletier J. Variable effects of three different chondroitin sulfates on human osteoarthritic cartilage: relevance of origin, purity and production process. J Rheumatol 2010, 37:656-664.
41. Hochberg M (to be completed by the OAC editor).